Bioqual Cash Flow from Investing Activities 2010-2024 | BIOQ
Bioqual cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Bioqual Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $-1 |
| 2023 | $-2 |
| 2022 | $-5 |
| 2021 | $-4 |
| 2020 | $-2 |
| 2019 | $-2 |
| 2018 | $-2 |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2013 | $ |
| 2012 | $ |
| 2011 | $ |
| 2010 | $ |
| 2009 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.051B | $0.059B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $18.777B | 18.97 |
| DaVita (DVA) | United States | $12.238B | 15.61 |
| Encompass Health (EHC) | United States | $10.200B | 22.86 |
| Chemed (CHE) | United States | $9.006B | 28.86 |
| Option Care Health (OPCH) | United States | $5.740B | 27.52 |
| Elanco Animal Health (ELAN) | United States | $5.213B | 11.54 |
| RadNet (RDNT) | United States | $3.681B | 78.92 |
| Amedisys (AMED) | United States | $3.039B | 21.49 |
| LifeStance Health (LFST) | United States | $2.561B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.797B | 20.82 |
| Astrana Health (ASTH) | United States | $1.554B | 34.84 |
| U.S Physical Therapy (USPH) | United States | $1.099B | 28.05 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.057B | 0.00 |
| Pennant (PNTG) | United States | $0.866B | 34.93 |
| Atai Life Sciences (ATAI) | Germany | $0.270B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.002B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |